Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps

Company Overview - Shares of Sanara MedTech Inc. (SMTI) have declined sharply, down nearly 40% for the year following the release of the company's Q3 earnings [1] Financial Performance - The company's fast-growing and profitable surgical segment has been overshadowed, indicating potential underlying issues despite growth in this area [1]